Cargando…
Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies
Background: Pancreatic cancer represents the most lethal malignancy among all digestive cancers. Despite the therapeutic advances achieved during recent years, the prognosis of this neoplasm remains disappointing. An enormous amount of experimental (mainly) and clinical research has recently emerged...
Autores principales: | Triantafillidis, John K., Triantafyllidi, Eleni, Sideris, Michail, Pittaras, Theodoros, Papalois, Apostolos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839014/ https://www.ncbi.nlm.nih.gov/pubmed/35276978 http://dx.doi.org/10.3390/nu14030619 |
Ejemplares similares
-
Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
por: Papalois, Apostolos E., et al.
Publicado: (2019) -
Herbal and plant therapy in patients with inflammatory bowel disease
por: Triantafyllidi, Aikaterini, et al.
Publicado: (2015) -
Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies
por: Triantafillidis, John K., et al.
Publicado: (2016) -
Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer
por: Triantafyllidi, Eleni, et al.
Publicado: (2022) -
Enteral Nutrition Supplemented with Transforming Growth Factor-β, Colostrum, Probiotics, and Other Nutritional Compounds in the Treatment of Patients with Inflammatory Bowel Disease
por: Triantafillidis, John K., et al.
Publicado: (2020)